Drugmakers and pharmacists battle over who gets to make obesity drugs
(By Sydney Lupkin for NPR) Ozempic and similar drugs for Type 2 diabetes and weight loss are in such high
Read More
Healthcare Finance
Future of Medicare drug price negotiations under new administration: 5 things to know
(By Alexandra Murphy for Becker’s Hospital Review) As President-elect Donald Trump prepares to take office, the future of Medicare’s drug
Read MoreMedicare Advantage 2025 Spotlight: A First Look at Plan Premiums and Benefits
(By Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Nov 15, 2024)
Read More5 benefits Medicare Advantage plans are cutting back for 2025
(By Rylee Wilson for Becker’s Hospital Review) Fewer Medicare Advantage insurers will offer remote access technologies and over-the-counter benefits in
Read MoreMedicare Advantage saves money
Medicare recipients who migrate from traditional Medicare to the Medicare Advantage program have saved the federal government $144 billion over
Read MoreWhat Administrative Changes Can Trump Make to Medicaid?
(By Robin Rudowitz, Jennifer Tolbert, Elizabeth Hinton, and Alice Burns for The Kaiser Family Foundation Published: Nov 08, 2024) With
Read MoreHospital-at-home, telehealth coverage to end: 5 updates
(By Giles Bruce for Becker’s Hospital Review) Hospital-at-home and telehealth reimbursement from CMS will expire at the end of 2024
Read MoreVA’s homelessness budget: Where the dollars go
(Source – news.va.gov) Each year, the federal government devotes billions of dollars to the noble goal of ending Veteran homelessness.
Read MoreSouth Dakota passes Medicaid work requirement measure
(By Andrew Cass for Becker’s Hospital Review) South Dakota voters have approved a ballot measure that allows state officials to
Read MoreMedicaid Coverage of and Spending on GLP-1s
(By Elizabeth Williams, Robin Rudowitz, and Clea Bell for The Kaiser Family Foundation Published: Nov 04, 2024) GLP-1 (glucagon-like peptide-1)
Read More